The adenovirus E4 ORF6 and E1b 55 kDa proteins cooperate in a p53-independent manner to enhance transduction by recombinant adeno-associated virus vectors

Journal of General Virology

Volumn 81, Issue 12, 2000, Pages 2983-2991

  Trahair, T N ^a   Alexander, I E ^a   Rowe, P B ^a   Smythe, J A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CONTROLLED STUDY; COOPERATION; GENE THERAPY; GENETIC TRANSDUCTION; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; HYPOTHESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRESS; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0034528836     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-12-2983     Document Type: Article

References (51)

1. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
2. Adenovirus-associated defective virus particles
3. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection
4. Evidence for a single-stranded adenovirus-associated virus genome: Isolation and separation of complementary single strands
5. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication
6. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells
7. p53 functions as a cell cycle control protein in osteosarcomas
8. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor
9. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
10. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
11. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
12. Adeno-associated virus vectors for gene therapy
13. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium
14. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells
15. Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells
16. High efficiency gene transfer into mammalian cells
17. Covalently closed circles of human adenovirus DNA are infectious
18. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
19. Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orfo protein
20. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells
21. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells
22. Latent infection of KB cells with adeno-associated virus type 2
23. p53, the cellular gatekeeper for growth and division
24. Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: Evidence for a high transduction efficiency into primary epithelial cancer cells
25. Adeno-associated virus general transduction vectors: Analysis of proviral structures
26. The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA
27. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
28. Oncogenic potential of the adenovirus E4orf6 protein
29. Use of adeno-associated virus as a general transduction vector for mammalian cells
30. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function
31. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs
32. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells
33. Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-associated virus
34. Adeno-associated virus vectors and hematology
35. Adeno-associated virus vectors preferentially transduce cells in S phase
36. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
37. Adenovirus E1B 55-Mr polypeptide facilities timely cytoplasmic accumulation of adeno-associated virus mRNAs
38. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
39. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
40. Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction
41. A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: Characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells
42. Adenovirus early region 1B 58000-dalton tumor antigen is physically associated with an early region 4 25000-dalton protein in productively infected cells
43. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes
44. Production of recombinant adeno-associated viral vectors
45. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells
46. The p53 tumour suppressor gene
47. Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers
48. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
49. Gene transfer by adeno-associated virus vectors into the central nervous system
50. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus